Article Versions Notes

Nagakawa Y, Nakagawa N, Takishita C, Uyama I, Kozono S, Osakabe H, Suzuki K, Nakagawa N, Hosokawa Y, Shirota T, et al. Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment. Cancers. 2021; 13(14):3605. https://doi.org/10.3390/cancers13143605

Nagakawa, Yuichi, Naoya Nakagawa, Chie Takishita, Ichiro Uyama, Shingo Kozono, Hiroaki Osakabe, Kenta Suzuki, Nobuhiko Nakagawa, Yuichi Hosokawa, Tomoki Shirota, and et al. 2021. "Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment" Cancers 13, no. 14: 3605. https://doi.org/10.3390/cancers13143605

Nagakawa, Y., Nakagawa, N., Takishita, C., Uyama, I., Kozono, S., Osakabe, H., Suzuki, K., Nakagawa, N., Hosokawa, Y., Shirota, T., Honda, M., Yamada, T., Katsumata, K., & Tsuchida, A. (2021). Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment. Cancers, 13(14), 3605. https://doi.org/10.3390/cancers13143605